Sage Bionetworks is a biomedical research organization that is an independent corporate entity leasing facilities at the Fred Hutchinson Cancer Research Center in Seattle, Washington. Sage Bionetworks is an IRS 501(c)(3) public charity incorporated as a non-profit in Washington State.

Sage Bionetworks is not operated by, sponsored by, endorsed by, or affiliated with SAGE Publications, Inc. in any way or manner. Sage Bionetworks does not publish academic and scholarly journals of any kind.

Sage Bionetworks is not operated by, sponsored by, endorsed by, or affiliated with The Sage Group plc. Sage Bionetworks does not supply accounting and business management software.

Sage Bionetworks is not operated by, sponsored by, endorsed by, or affiliated with Sage Manufacturing. Sage Bionetworks does not manufacture or distribute sporting equipment.

All material on the Sage Bionetworks and Sage Bionetworks Commons Congress web sites is covered under the terms of the Creative Commons Attribution 3.0 Unported license except where otherwise noted. You are free to share, remix and make commercial use provided that you clearly attribute Sage Bionetworks.

In accordance with the Public Health Service (“PHS”) Financial Conflict of Interest regulation (42 CFR Part 50 Subpart F and 45 CFR Part 94), Sage Bionetworks will make certain information regarding financial conflicts of interest of senior/key personnel on PHS-funded research projects available upon written request.  Requests for information regarding such financial conflicts of interest may be made by sending an e-mail with “Financial Conflict of Interest Request” in the subject line to info@sagebase.org or by mail to the following address:

Sage Bionetworks
Attn: Financial Conflict of Interest Request
1100 Fairview Ave North
MS: M1-C108
Seattle, WA  98109-1024

We will respond within five business days of receipt of a written request.  The information that will be made available will be consistent with the PHS regulation.

PDF iconConflict of Interest Policy

PDF icon Sage Bionetworks negotiated F&A Rate agreement